Ubs Group Ag Amedisys Inc Transaction History

Ubs Group Ag

$452 Billion
Q3 2024

A detailed history of Ubs Group Ag transactions in Amedisys Inc stock. As of the latest transaction made, Ubs Group Ag holds 40,314 shares of AMED stock, worth $3.41 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

40,314

Previous 62,337 35.33%

Holding current value

$3.41 Million

Previous $5.72 Million 32.02%

% of portfolio

0.0%

Previous 0.0%

31 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	SELL	$96.5 - $98.45 $2.13 Million - $2.17 Million	-22,023 Reduced 35.33%	40,314 $3.89 Million
Q2 2024 Aug 13, 2024	SELL	$90.4 - $96.77 $1.15 Million - $1.23 Million	-12,745 Reduced 16.97%	62,337 $5.72 Million
Q1 2024 May 13, 2024	BUY	$92.15 - $95.24 $6.18 Million - $6.39 Million	67,097 Added 840.29%	75,082 $6.92 Million
Q4 2023 Feb 09, 2024	SELL	$91.15 - $95.89 $3.13 Million - $3.29 Million	-34,316 Reduced 81.12%	7,985 $759,000
Q3 2023 Nov 09, 2023	BUY	$89.84 - $94.08 $2.93 Million - $3.07 Million	32,610 Added 336.5%	42,301 $3.95 Million
Q2 2023 Aug 11, 2023	SELL	$73.99 - $92.6 $698,465 - $874,144	-9,440 Reduced 49.34%	9,691 $886,000
Q1 2023 May 12, 2023	BUY	$69.79 - $100.33 $118,433 - $170,260	1,697 Added 9.73%	19,131 $1.41 Million
Q4 2022 Feb 08, 2023	SELL	$80.12 - $105.34 $3.1 Million - $4.07 Million	-38,671 Reduced 68.93%	17,434 $1.46 Million
Q3 2022 Nov 10, 2022	BUY	$96.79 - $131.14 $138,603 - $187,792	1,432 Added 2.62%	56,105 $5.43 Million
Q2 2022 Aug 10, 2022	BUY	$105.12 - $173.85 $857,568 - $1.42 Million	8,158 Added 17.54%	54,673 $5.75 Million
Q1 2022 May 16, 2022	BUY	$124.79 - $178.09 $303,364 - $432,936	2,431 Added 5.51%	46,515 $8.01 Million
Q4 2021 Feb 14, 2022	SELL	$136.32 - $184.41 $3.16 Million - $4.27 Million	-23,145 Reduced 34.43%	44,084 $7.14 Million
Q3 2021 Nov 15, 2021	BUY	$149.1 - $270.32 $7.25 Million - $13.1 Million	48,622 Added 261.31%	67,229 $10 Million
Q2 2021 Aug 13, 2021	BUY	$238.97 - $288.5 $598,858 - $722,981	2,506 Added 15.56%	18,607 $4.56 Million
Q1 2021 May 12, 2021	SELL	$236.62 - $314.16 $465,668 - $618,266	-1,968 Reduced 10.89%	16,101 $4.26 Million
Q4 2020 Feb 11, 2021	BUY	$231.3 - $293.33 $393,903 - $499,540	1,703 Added 10.41%	18,069 $5.3 Million
Q3 2020 Nov 12, 2020	SELL	$199.22 - $248.1 $23,308 - $29,027	-117 Reduced 0.71%	16,366 $3.87 Million
Q2 2020 Jul 31, 2020	BUY	$169.77 - $213.81 $153,302 - $193,070	903 Added 5.8%	16,483 $3.27 Million
Q1 2020 May 01, 2020	SELL	$137.21 - $202.02 $4.15 Million - $6.11 Million	-30,230 Reduced 65.99%	15,580 $2.86 Million
Q4 2019 Feb 14, 2020	BUY	$122.85 - $167.13 $637,591 - $867,404	5,190 Added 12.78%	45,810 $7.65 Million
Q3 2019 Nov 14, 2019	BUY	$117.97 - $137.89 $2.58 Million - $3.02 Million	21,866 Added 116.59%	40,620 $5.32 Million
Q2 2019 Aug 14, 2019	SELL	$108.08 - $129.67 $2.25 Million - $2.7 Million	-20,851 Reduced 52.65%	18,754 $2.28 Million
Q1 2019 May 14, 2019	BUY	$110.76 - $138.73 $614,274 - $769,396	5,546 Added 16.28%	39,605 $4.88 Million
Q4 2018 Feb 14, 2019	BUY	$98.2 - $140.23 $960,101 - $1.37 Million	9,777 Added 40.26%	34,059 $3.99 Million
Q3 2018 Nov 14, 2018	SELL	$87.74 - $125.01 $3.36 Million - $4.79 Million	-38,293 Reduced 61.2%	24,282 $3.03 Million
Q2 2018 Aug 14, 2018	BUY	$60.06 - $87.93 $3.24 Million - $4.74 Million	53,952 Added 625.68%	62,575 $5.35 Million
Q1 2018 May 15, 2018	SELL	$50.51 - $62.74 $99,504 - $123,597	-1,970 Reduced 18.6%	8,623 $520,000
Q4 2017 Feb 14, 2018	SELL	$46.45 - $58.49 $21,134 - $26,612	-455 Reduced 4.12%	10,593 $558,000
Q3 2017 Nov 14, 2017	SELL	$47.05 - $55.96 $24,136 - $28,707	-513 Reduced 4.44%	11,048 $618,000
Q2 2017 Aug 14, 2017	BUY	N/A	202 Added 1.78%	11,561 $727,000
Q1 2017 Nov 14, 2017	BUY	N/A	11,359	11,359 $580,000

Others Institutions Holding AMED

# of Institutions

297

Shares Held

28.5M

Call Options Held

181K

Put Options Held

1.04M

View Full List

About AMEDISYS INC

Ticker AMED
Exchange NASDAQ
Sector Healthcare
Industry Medical Care Facilities
Shares Outstandng 32,492,000
Market Cap $2.74B
Description
Amedisys, Inc., together with its subsidiaries, provides healthcare services in the United States. It operates through three segments: Home Health, Hospice, Personal Care, and High Acuity Care. The Home Health segment offers a range of services in the homes of individuals for the recovery of patients from surgery, chronic disability, or terminal...

More about AMED

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Ubs Group Ag, based on Form 13F filings with the SEC.

News

Stay updated on Ubs Group Ag with notifications on news.

Account